MOHAMMAD AL SHROOF: Open Payments
NPI 1578519286 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,240 in 162 payments from 36 companies in 2025. Trend: 2023 $3,252 · 2024 $3,433 · 2025 $3,240
Food & beverage: $3,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $357 |
| PFIZER INC. | 20 | $354 |
| AstraZeneca Pharmaceuticals LP | 14 | $266 |
| Otsuka America Pharmaceutical, Inc. | 11 | $238 |
| Novo Nordisk Inc | 9 | $201 |
| Eisai Inc. | 3 | $167 |
| Amgen Inc. | 11 | $145 |
| Lilly USA, LLC | 11 | $143 |
| BETA BIONICS, INC. | 2 | $139 |
| Astellas Pharma US Inc | 5 | $103 |
Products named: REXULTI, NURTEC ODT, FARXIGA, Leqembi, iLet Bionic Pancreas, ELIQUIS, VRAYLAR, LINZESS.
Industry payments across GA — which companies pay providers there.
